Drugmaker Slumps as FDA Keeps Hold on Lung Treatment Trial - Oct. 10, 2011

Having trouble viewing this email? View in Browser.

Monday, October 10, 2011  |   |   |   |  Ambion® Products...Superior Results Every Time Ambion® Products Represent Years of RNA Expertise. For over two decades, our scientists have developed high-quality, innovative RNA products that make your job easier with faster, more robust and more reliable results. Use the best and have confidence in your results...every time. Now, Ambion® products also include Invitrogen™ RNA products - all by Life Technologies. Please click here for more information.   •  Drugmaker Slumps as FDA Keeps Hold on Lung Treatment Trial More... •  Biotron Limited (BIT:AU) Shares Soar on Hepatitis C Phase 2a Positive Results More... •  FDA Approves Boehringer Ingelheim Pharmaceuticals, Inc.'s Combivent(R) Respimat(R) (ipratropium bromide and albuterol) Inhalation Spray for the Treatment of Patients with Chronic Obstructive Pulmonary Disease More... •  Zosano Pharma, Inc. and Asahi Kasei Pharma (AHKSY.PK) Enter Exclusive Licensing Agreement for a Weekly Transdermal Patch Formulation of Teribone(TM) (teriparatide acetate) More... •  Dynavax Technologies Corporation (DVAX) Reports Positive Immunogenicity Data From an Analysis of Hypo-Responsive Populations in HEPLISAV(TM) Phase 3 Trial More... •  United Therapeutics Corporation (UTHR) Subsidiary Enters into Contract With National Institutes of Health (NIH) for Award of up to $45 Million to Support Glycobiology Antiviral Program; 20 New Jobs Created More... •  £7.6 Million Funding Package Secured for Third Building at Liverpool Science Park; 7,000 Jobs Ahead More... •  Daval International Limited Announces Positive Phase II Results for AIMSPRO(R) as a Monotherapy in Established Diffuse Cutaneous Systemic Sclerosis (Scleroderma) More... More Top News BASF Custom Synthesis BASF offers exclusive development and manufacturing services for active ingredients and advanced intermediates. Our team of experts provides support throughout the drug lifecycle - from the early clinical phase, through the exclusivity period, and later during the generic phase of a drug life cycle. For more information, please visit: www.custom-synthesis.basf.com. •  Can Text Messages be Used to Improve Health Outcomes? More... •  HIV: Ancient Gene Found to Control Potent Antibody Response to Retroviruses, Massachusetts Institute of Technology (MIT) Study More... •  Three New Gene Faults Found to Increase Melanoma Risk by 30 Percent, Cancer Research UK Cambridge Research Institute Study More... •  Boys With Autism May Grow Faster as Babies, Yale University Study More... •  If You Don't Snooze, Do You Lose? Wake-Sleep Patterns Affect Brain Synapses During Adolescence, University of Wisconsin-Madison Study More... •  Sniffing out the Brain's Predictive Power: Human Brain 'Smells' What It Expects Rather Than What It Sniffs, Northwestern University Feinberg School of Medicine Study More... •  Dana-Farber Cancer Institute Slams New Prostate-Cancer Test Guidelines More... •  Biotech Employment Grows Over 600% In California More...   More Featured News IBC's BioProcess International Conference & Exhibition October 31 - November 4, 2011 - Long Beach, California Event Website Download the 2011 BioProcess International brochure and see why this is YOUR must attend event for 2011. Download your PDF here. You will see the 2011 program, features a stellar line up keynote presentations including, the US FDA, EMA, Pfizer, Merck and more. Plus, there are over 50 presentations with new, previously unpublished data, and new topic coverage areas including antibody drug conjugates, viral clearance and managing global manufacturing facilities and partners. Exhibit hall & keynote passes are now available. Mention priority code B11171BSEODS2 and the fee will be waived. All passes subject to approval. Register here today or call 800-390-4078. The Hepatitis Market Outlook to 2016 • Understand how recent events are affecting the performance of major products, and how their marketers are confronting competitive market changes. • Compare the franchises of the leading companies in the hepatitis market, and understand how the market share of these companies will change. • Evaluate pipeline compounds for the treatment of hepatitis and determine which products will provide the greatest revenue growth. • Understand the market dynamics and interactions between the key drug classes used in the treatment of hepatitis. Click Here for More Information. Drug Discovery & Development Drug Discovery & Development magazine delivers vital insight about the latest technologies and tools used to develop pharmaceutical products to key decision-makers Request Now! • BioMidwest (Madison, Wisconsin) Promega Corporation Director, Process Development We are seeking a Director of Process Development to join our Operations Division. This role will be part of a dynamic team providing technical support for upstream and downstream processing, which includes a strong research pipeline that demands rapid development and tech transfer to production environments. • Pharm Country (Radnor, Pennsylvania) PolyMedix, Inc. Clinical Trial Operations Manager/Director Experience in execution of Phase II Phase II pivotal studies, Phase III and small Phase I studies and larger, multi-center trial management. Experience in infectious diseases and/or cardio vascular. Well versed in GCP and applicable FDA/EMEA regulations required. Ability to prepare and present clinical trial updates to senior management. • Biotech Bay (South San Francisco, California) Genentech, Inc Scientist / Senior Scientist, Analytical Chemistry Will be responsible for the life cycle management of Genentech's entire biotech commercial quality control methods, control systems/specifications and assay transfers. He/ she will be accountable for global assay troubleshooting and optimization; assay development, validation and comparability studies; investigations and CAPAs across Genentech's entire commercial biotech testing sites (including CMOs and partners). • Biotech Beach (San Diego, California) Synteract, Inc. Regional Clinical Research Associate Will assist in all aspects of clinical trials management, including initiating, investigating and monitoring of clinical studies. Position will be regional and home-based. • Bio NC (Northcove, North Carolina) Baxter International, Inc. Supervisor I, Manufacturing Responsible for implementing and supervising daily maintenance activities in a specific production area to ensure manufacturing goals and project deadlines are met while maintaining compliance with current good manufacturing practices (GMPs), environmental health and safety (EHS) guidelines and any other regulations that could apply. Get Noticed! Add your resume to the BioSpace Career Center! See more than 5,000 job postings in the BioSpace Career Center! Biotech Bay Career Fair Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Bay area region. Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.) Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research. Job seekers may register here. • Biotech Bay Career Fair, Burlingame, CA October 11, 2011 • Bio NC Career Fair, Durham, NC October 20, 2011 • BioCapital Beach Career Fair, Bethesda, MD November 1, 2011 • Genetown Career Fair, Cambridge, MA November 7, 2011 More information about BioSpace's Career Fairs BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience By June Salvati, BioSpace Director of Events and Corporate Services InterMune, Inc. 3280 Bayshore Boulevard Brisbane California 94005 U.S.A. Phone: 415-466-2200 Fax: 415-466-2329 InterMune is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and hepatology. InterMune has a product portfolio addressing IPF and HCV infections. . The pulmonology portfolio includes Actimmune®, which is being evaluated in the INSPIRE Trial, a Phase III study in patients with IPF, and pirfenidone, which is also being developed for the treatment of IPF. More Company Profiles FREE Subscription to Medical Product Outsourcing Their in-depth coverage includes comprehensive feature articles, industry news, trends and other developments pertinent to the CM-OEM relationship. Medical Product Outsourcing examines the increasingly complex and demanding requirements of managing outsourcing partnerships. Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship BioSpace Inc. 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 BioSpace Inc. 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 Send questions and comments to the BioSpace News Beat Team. Editor & Publisher: Rosemary Do Editorial & Production Staff: Lana Ho, Suvarna Sheth, Maysa Darwish, Tammy Liu BioSpace.com - Life. Science. Community. • BioSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2011 BioSpace http://www.biospace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here. Safely unsubscribe from Biospace.com e-mail at any time by managing your account here.